In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae. [PDF]
Antimicrob Agents Chemother, 1986 Jorgensen JH, Redding JS, Howell AW.
europepmc +1 more source
Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice. [PDF]
Antimicrob Agents Chemother, 1986 Chan J, Luft BJ.
europepmc +1 more source
Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells. [PDF]
Antimicrob Agents Chemother, 1987 Misu T +4 more
europepmc +1 more source
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. [PDF]
Antimicrob Agents Chemother, 1987 Barry AL, Thornsberry C, Jones RN.
europepmc +1 more source
Roxithromycin disposition in tonsils after single and repeated administrations. [PDF]
Antimicrob Agents Chemother, 1988 Galioto GB +5 more
europepmc +1 more source
X-Ray Crystallographies of Leucomycin A5 and Rokitamycin Monomethylacetal.
The Journal of Antibiotics, 1997 K, Yamashita, K, Kinoshita
openaire +3 more sources
In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi. [PDF]
Antimicrob Agents Chemother, 1986 Sanson-Le Pors MJ +4 more
europepmc +1 more source
Effect of roxithromycin on acute toxoplasmosis in mice. [PDF]
Antimicrob Agents Chemother, 1987 Chang HR, Pechere JC.
europepmc +1 more source